Comparison of the Effectiveness of F. assa-foetida and Placebo on Antihyperglycemic, Antihyperlipidemic, Anti-inflammatory, and Antioxidant Activities in Type 2 Diabetes Mellitus Patients

Abadan University of Medical Sciences0 个研究点目标入组 66 人开始时间: 待定最近更新: 2019年11月5日

适应症

试验速览

暂无简介。

•Age 25-25 years
•Male and female patients
•Completion of diagnostic criteria for type 2 diabetes mellitus
•The desire to participate in the study with the ability to understand the relevant information and complete the informed consent form

•Use of warfarin and other coumarin substitutes by the patient
•Use of increasing blood glucose drugs such as antidepressants (triangles), beta-adrenergic blockers, corticosteroids, diazoxide, diuretics, epinephrine, estrogen, glucagon, isoniazid, lithium, phenothiazines, phenytoin, salicylates and triamterene
•Use of glucose lowering drugs, including acetaminophen, alcohol, anabolysin steroids, gemfibrosil, monoamine oxidase inhibitors, propranolol, tolazamide, and tolbutamide
•History of uncontrolled hypertension, congestive heart failure and other cardiovascular disease, liver disease, kidney disease, or any metabolic and clinical disorder, except diabetes mellitus
•Patients with dangerous disease
•Renal dysfunction (glomerular filtration rate less than 60 ml / min / 1.73 mm3 of surface area)
•Participants with recent weight loss or weight gain more than 5% of body weight within 3 months
•People with type 1 diabetes or other chronic diseases such as stroke and cancer that may affect physical activity
•Pregnant and lactating women
•People with psychological illnesses
•Patient with type 2 diabetes under insulin therapy
•Smoking during the testing period (increasing blood glucose levels)
•Patients with sickle cell anemia, thalassemia, Chronic renal failure affecting the hemoglobin A1c
•Any circumstances that, according to the researcher, do not justify the participation of individuals in the study

发起方

Abadan University of Medical Sciences